These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 21187605

  • 1. [Measurement of bone mineral density is unnecessary for monitoring of bisphosphonate treatment].
    Nishida A, Ito M.
    Clin Calcium; 2011 Jan; 21(1):120-3. PubMed ID: 21187605
    [Abstract] [Full Text] [Related]

  • 2. [Measurement of bone mineral density is necessary for monitoring of bisphosphonate treatment].
    Soen S.
    Clin Calcium; 2011 Jan; 21(1):116-9. PubMed ID: 21187604
    [Abstract] [Full Text] [Related]

  • 3. [Image assessment of the treatment effect on osteoporosis: bisphosphonates].
    Sone T.
    Clin Calcium; 2011 Jul; 21(7):1041-6. PubMed ID: 21719985
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of osteoporosis treatment efficacy by bone mass measurement].
    Miki T, Tomiyoshi Y.
    Clin Calcium; 2004 Dec; 14(12):19-26. PubMed ID: 15577169
    [Abstract] [Full Text] [Related]

  • 5. Risks of osteoporosis associated with breast cancer treatment: the need to access to preventive treatment.
    Rozenberg S, Carly B, Liebens F, Antoine C.
    Maturitas; 2009 Sep 20; 64(1):1-3. PubMed ID: 19709824
    [Abstract] [Full Text] [Related]

  • 6. Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond.
    Davison KS, Kendler DL, Ammann P, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, McClung MR, Olszynski WP, Yuen CK.
    Am J Med; 2009 Nov 20; 122(11):992-7. PubMed ID: 19854322
    [Abstract] [Full Text] [Related]

  • 7. Underdiagnosis and under-treatment of osteoporosis following fragility fracture.
    Aboyoussef M, Vierkoetter KR.
    Hawaii Med J; 2007 Jul 20; 66(7):185-7. PubMed ID: 17879856
    [Abstract] [Full Text] [Related]

  • 8. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
    Skordis N, Ioannou YS, Kyriakou A, Savva SC, Efstathiou E, Savvides I, Christou S.
    Pediatr Endocrinol Rev; 2008 Oct 20; 6 Suppl 1():144-8. PubMed ID: 19337169
    [Abstract] [Full Text] [Related]

  • 9. Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
    Emkey RD, Ettinger M.
    Am J Med; 2006 Apr 20; 119(4 Suppl 1):S18-24. PubMed ID: 16563937
    [Abstract] [Full Text] [Related]

  • 10. [Diagnosis and treatment of osteoporosis in men].
    Hosoi T.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():495-8. PubMed ID: 18161155
    [No Abstract] [Full Text] [Related]

  • 11. [Bone diseases with Pain. Osteoporosis].
    Hayashi Y.
    Clin Calcium; 2007 Apr 28; 17(4):606-12. PubMed ID: 17404492
    [Abstract] [Full Text] [Related]

  • 12. What is the optimal duration of bisphosphonate therapy?
    Ott SM.
    Cleve Clin J Med; 2011 Sep 28; 78(9):619-30. PubMed ID: 21885695
    [Abstract] [Full Text] [Related]

  • 13. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP.
    Arch Intern Med; 2003 Oct 13; 163(18):2237-46. PubMed ID: 14557222
    [Abstract] [Full Text] [Related]

  • 14. Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service.
    Harrington JT, Lease J.
    Arthritis Rheum; 2007 Dec 15; 57(8):1502-6. PubMed ID: 18050169
    [Abstract] [Full Text] [Related]

  • 15. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
    Fukunaga M.
    Clin Calcium; 2009 Jan 15; 19(1):63-73. PubMed ID: 19122266
    [Abstract] [Full Text] [Related]

  • 16. Clinical applications of bone density testing for osteoporosis.
    Lewiecki EM.
    Minerva Med; 2005 Oct 15; 96(5):317-30. PubMed ID: 16227947
    [Abstract] [Full Text] [Related]

  • 17. [Primary osteoporosis--its diagnosis and treatment].
    Inaba M.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():485-9. PubMed ID: 18161153
    [No Abstract] [Full Text] [Related]

  • 18. Uptake of treatment for osteoporosis and compliance after bone density measurement in the community.
    Dugard MN, Jones TJ, Davie MW.
    J Epidemiol Community Health; 2010 Jun 28; 64(6):518-22. PubMed ID: 19679704
    [Abstract] [Full Text] [Related]

  • 19. Osteoporosis risk in premenopausal women.
    Vondracek SF, Hansen LB, McDermott MT.
    Pharmacotherapy; 2009 Mar 28; 29(3):305-17. PubMed ID: 19249949
    [Abstract] [Full Text] [Related]

  • 20. Who will benefit from antiresorptive treatment (bisphosphonates)?
    Papapoulos SE.
    Best Pract Res Clin Rheumatol; 2005 Dec 28; 19(6):965-73. PubMed ID: 16301190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.